You will have a hard time finding any other biotech/biopharma in Phase 1 with less than $100 million in market cap. Radiopharmaceutical companies are getting huge interest from investors. Bayer, the giant German drug company, just acquired two of them. https://www.biopharmadive.com/news/bayer-noria-psma-prostate-cancer/601211/